Business of Medicine
MedPAC says the Merit-based Incentive Payment System won’t fulfill its goals and should be eliminated.
When you get the right people, count yourself lucky and do what you have to do to keep them, says Dr. Allan M. Block.
And why confusion reigns over the COPD-asthma overlap.
Daily News Podcast
And how excessive daytime sleepiness could lead to dementia.
And there’s pushback against new blood sugar targets.
And alirocumab cuts deaths in post–acute coronary syndrome patients.
The U.S. hemophilia drug market, which serves about 20,000 patients, is worth $4.6 billion a year.
Pharmacy benefits manager reports increased use of drugs to treat opioid dependence.
WASHINGTON – FDA Commissioner calls for more competition in biologic products.
“There aren’t a lot of options available to Medicaid programs in terms of controlling costs, because we don’t set the initial costs”